NuScale Power Jumps 15.14% with 62.6M Shares Traded on Nuclear Policy Push
NuScale surged 15.14% on Jan. 5, trading 62.6 million shares (157% above its three-month average) driven by U.S. House nuclear policy discussions and last summer’s NRC approval of its latest reactor design. Despite a 30% gain in early 2026, shares remain down 9% over the past year after the company doubled its authorized capital stock at year-end 2025, diluting existing shareholders.
1. SMR Shares Soar on Renewed Nuclear Policy Focus
NuScale Power’s shares jumped by more than 15 percent on January 5, driven by heightened investor interest in small modular reactors (SMRs) and fresh discussions in the U.S. House of Representatives regarding nuclear energy policy. Trading volume on the NYSE-listed stock reached nearly 63 million shares, approximately 2.6 times its three-month average, underscoring the intensity of the rally. The company’s market capitalization now stands at roughly 4.6 billion dollars, positioning it as one of the most closely watched names in the clean-energy transition space.
2. Regulatory Milestone Strengthens Long-Term Outlook
In the summer of 2025, the Nuclear Regulatory Commission granted final approval for NuScale’s latest SMR plant design, a critical step toward commercial deployment. The design’s modular construction is expected to reduce on-site assembly times by up to 30 percent compared with traditional reactors, potentially lowering capital expenditures on future projects. With multiple pilot units slated for deployment beginning in the latter half of the decade, approval by the NRC enhances SMR’s credibility with utility partners and federal agencies seeking scalable, low-carbon power solutions.
3. Capital Stock Increase Creates Dilution Concerns
Despite the strong start to 2026—shares are up more than 30 percent year-to-date—NuScale remains down roughly 9 percent over the past twelve months. At the end of 2025, the company nearly doubled its authorized capital stock, raising questions about shareholder dilution and governance. While the move provided additional firepower for R&D and project financing, long-term investors have expressed concern that future equity issuances could weigh on per-share metrics and delay the path to profitability.